Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Labelling - Supply - COVID
Other Recent Recalls
PegLyte Powder
PegLyte Powder: Affected lots may contain foreign matter
Type III2026-11-17
Low health risk
Taro-Candesartan tablets
TARO-CANDESARTAN: affected lots may contain Esomeprazole 20mg capsules
Type II2026-11-16
Moderate health risk
SECARIS NASAL GEL
SECARIS NASAL GEL: Affected lot may contain foreign matter
Type II2026-11-13
Moderate health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.